Rodgers Brothers Inc. Eli Lilly & CO Transaction History

Rodgers Brothers Inc.

  • $690 Million
  • Q2 2024

A detailed history of Rodgers Brothers Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Rodgers Brothers Inc. holds 61,583 shares of LLY stock, worth $56 Million. This represents 8.08% of its overall portfolio holdings.

Number of Shares
61,583
Previous 62,797 1.93%
Holding current value
$56 Million
Previous $48.9 Million 14.13%
% of portfolio
8.08%
Previous 7.14%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$724.87 - $909.04 $879,992 - $1.1 Million
-1,214 Reduced 1.93%
61,583 $55.8 Million
Q1 2024

May 14, 2024
SELL
$592.2 - $792.28 $1.56 Million - $2.09 Million
-2,640 Reduced 4.03%
62,797 $48.9 Million
Q4 2023

Feb 13, 2024
SELL
$525.19 - $619.13 $1.13 Million - $1.33 Million
-2,155 Reduced 3.19%
65,437 $38.1 Million
Q3 2023

Nov 13, 2023
SELL
$434.7 - $599.3 $126,932 - $174,995
-292 Reduced 0.43%
67,592 $36.3 Million
Q2 2023

Aug 14, 2023
SELL
$350.74 - $468.98 $212,548 - $284,201
-606 Reduced 0.88%
67,884 $31.8 Million
Q1 2023

May 15, 2023
SELL
$310.63 - $364.82 $105,614 - $124,038
-340 Reduced 0.49%
68,490 $23.5 Million
Q4 2022

Feb 14, 2023
SELL
$321.55 - $374.67 $541,168 - $630,569
-1,683 Reduced 2.39%
68,830 $25.2 Million
Q3 2022

Nov 14, 2022
SELL
$296.48 - $337.87 $1.89 Million - $2.15 Million
-6,360 Reduced 8.27%
70,513 $22.8 Million
Q2 2022

Aug 15, 2022
SELL
$278.73 - $327.27 $1.73 Million - $2.03 Million
-6,200 Reduced 7.46%
76,873 $24.9 Million
Q1 2022

May 16, 2022
SELL
$234.69 - $291.66 $265,199 - $329,575
-1,130 Reduced 1.34%
83,073 $23.8 Million
Q4 2021

Feb 14, 2022
SELL
$224.85 - $279.04 $38,899 - $48,273
-173 Reduced 0.21%
84,203 $23.3 Million
Q3 2021

Nov 15, 2021
BUY
$221.6 - $272.71 $52,740 - $64,904
238 Added 0.28%
84,376 $19.5 Million
Q2 2021

Aug 16, 2021
SELL
$180.55 - $233.54 $139,926 - $180,993
-775 Reduced 0.91%
84,138 $19.3 Million
Q1 2021

May 17, 2021
BUY
$164.32 - $212.72 $76,408 - $98,914
465 Added 0.55%
84,913 $15.9 Million
Q4 2020

Feb 16, 2021
SELL
$130.46 - $172.63 $156,552 - $207,156
-1,200 Reduced 1.4%
84,448 $14.3 Million
Q3 2020

Nov 13, 2020
SELL
$146.22 - $169.13 $121,362 - $140,377
-830 Reduced 0.96%
85,648 $12.7 Million
Q2 2020

Aug 13, 2020
SELL
$136.42 - $164.18 $823,567 - $991,154
-6,037 Reduced 6.53%
86,478 $14.2 Million
Q1 2020

May 14, 2020
SELL
$119.05 - $147.35 $175,479 - $217,193
-1,474 Reduced 1.57%
92,515 $12.8 Million
Q4 2019

Feb 13, 2020
SELL
$106.92 - $132.43 $74,630 - $92,436
-698 Reduced 0.74%
93,989 $12.4 Million
Q3 2019

Nov 14, 2019
BUY
$106.79 - $116.16 $894,473 - $972,956
8,376 Added 9.7%
94,687 $10.6 Million
Q2 2019

Aug 14, 2019
BUY
$110.79 - $129.32 $223,795 - $261,226
2,020 Added 2.4%
86,311 $9.56 Million
Q1 2019

May 15, 2019
SELL
$111.31 - $131.02 $161,399 - $189,979
-1,450 Reduced 1.69%
84,291 $10.9 Million
Q4 2018

Feb 14, 2019
BUY
$105.9 - $118.64 $2,647 - $2,966
25 Added 0.03%
85,741 $9.92 Million
Q3 2018

Nov 14, 2018
SELL
$85.86 - $107.31 $700,274 - $875,220
-8,156 Reduced 8.69%
85,716 $9.2 Million
Q2 2018

Aug 14, 2018
BUY
$75.7 - $86.88 $3,936 - $4,517
52 Added 0.06%
93,872 $8.01 Million
Q1 2018

May 15, 2018
BUY
$74.21 - $87.6 $451,196 - $532,608
6,080 Added 6.93%
93,820 $7.26 Million
Q4 2017

Feb 14, 2018
SELL
$81.94 - $87.89 $26,466 - $28,388
-323 Reduced 0.37%
87,740 $7.41 Million
Q3 2017

Nov 08, 2017
BUY
$77.07 - $85.54 $6.79 Million - $7.53 Million
88,063
88,063 $7.53 Million

Others Institutions Holding LLY

# of Institutions
3,887
Shares Held
763M
Call Options Held
6.34M
Put Options Held
7.97M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $864B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Rodgers Brothers Inc. Portfolio

Follow Rodgers Brothers Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rodgers Brothers Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rodgers Brothers Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email